Stock AnalizSynopsys Inc. SNPS
Computer Software: Prepackaged Software · IPO 1992 · data as of November 13, 2026
Synopsys Inc. (SNPS) is a technology company listed in the US with a market value of about $87.2B. In the twelve months to July 31, 2026 it had revenue of $9.4B and net income of $1.1B, a net margin of 11.4%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is track record (4/5); the weakest is value (0/5).
Key numbers: a P/E of 79.6, a price to free cash flow of 31.7, 5-year revenue growth of 14% a year, a 5-year average ROIC of 12%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 28% below the current price.
Score: 2.0 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
- More cash than debt, or low debt to equity
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- ROE above 15%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.4B | $7.1B | $6.1B | $5.3B | $5.1B | $4.2B | $3.7B | $3.4B | $3.1B | $2.7B | $2.4B |
| Net income | $1.1B | $1.3B | $2.3B | $1.2B | $985M | $758M | $664M | $532M | $433M | $137M | $267M |
| Free cash flow | $2.7B | $1.3B | $1.3B | $1.5B | $1.6B | $1.4B | $837M | $602M | $325M | $562M | $520M |
| EPS (diluted) | $5.72 | $8.04 | $14.51 | $7.92 | $6.29 | $4.81 | $4.27 | $3.45 | $2.82 | $0.88 | $1.73 |
| Net margin | 11.4% | 18.9% | 36.9% | 23.1% | 19.4% | 18.0% | 18.0% | 15.8% | 13.9% | 5.0% | 11.0% |
| ROIC | — | 2.1% | 13.1% | 17.3% | 16.3% | 11.6% | 8.8% | 12.0% | 7.2% | 8.0% | 7.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 25 analysts is $589.55, 30% above the current price; targets range from $475.00 to $700.00; the consensus rating is “Strong buy”; expected EPS is $15.14 for the fiscal year ending October 31, 2026.
Frequently asked questions
What is Synopsys’s P/E ratio?
About 79.6, based on the last twelve months of diluted earnings per share (forward P/E about 25.4).
Is Synopsys stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 28% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Synopsys pay a dividend?
Not currently.
Is Synopsys a good stock to buy?
We do not give buy or sell advice. Synopsys scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.